Search results
9 lis 2017 · Here, we report the influence of various characteristics of the original tumor on the 20-year incidence of breast-cancer outcomes in women with ER-positive, early-stage breast cancer who were...
8 mar 2022 · Levonorgestrel intrauterine sustained release system (LNG-IUS) is an intrauterine hormonal contraceptive device. Breast cancer (BC) was the most common type of cancer in women in the world in 2020. The relationship between LNG-IUS and BC is controversial.
16 paź 2024 · By Nina Agrawal. Published Oct. 16, 2024 Updated Oct. 17, 2024. A study published Wednesday found that women using contraceptive intrauterine devices that deliver a certain hormone are at increased...
7 gru 2017 · The overall absolute increase in breast cancers diagnosed among current and recent users of any hormonal contraceptive was 13 (95% CI, 10 to 16) per 100,000 person-years, or approximately 1...
The effect of LNG-IUS on breast cancer risk seems to be larger in older users. However, our systematic review detected methodological issues across the available studies, and confounding factors may be responsible for at least a fraction of the risk effects associated with LNG-IUS use.
3 dni temu · There are two different ways researchers express risk: "relative" and "absolute" risks. Here, the "relative" risk increase was about 30% for women using the IUDs for up to five years, 40% after 5 ...
16 paź 2024 · Hormone-releasing intrauterine devices (IUDs) are associated with a slightly higher risk of breast cancer among young women, according to a large new Danish study.
